, ritonavir) or discontinuation of the cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin, may well bring about an increase in codeine plasma concentrations with subsequently higher metabolism by cytochrome P450 2D6, resulting in greater morphine levels, which could improve or lengthen adverse reactions and will result in https://akorn-promethazine-codein58045.ssnblog.com/31482749/the-2-minute-rule-for-akorn-codeine